Culturally Adapted Adolescent Substance Use Treatment
BehavioralThe Cannabis Youth Treatment Series (CYT) (MET/CBT12 model) aims to reduce alcohol and cannabis use.
Other names: Cannabis Youth Treatment Series
NCT Number: NCT06003725
This project aims to improve the understanding of the impact of Ethnic and Racial Discrimination (ERD) on adolescent alcohol and other drug use (AOD) within the Black Justice-Involved Youth (JIY) population. Individual interviews with Black JIY and focus groups with parents and guardians of Black JIY and community members who support change and reform in the justice community for Black JIY will be conducted.
Interested in participating?
Request Info13 year–17 year
All sexes
Interventional
Not applicable
University of California, San Francisco, San Francisco, California, United States
Black JIY are overrepresented in the criminal justice system due to institutional racism and discrimination. The General Strain Theory posits that high levels of ethnic and racial discrimination (ERD), paired with elevated levels of witnessing or experiencing police brutality, places Black JIY at unique risk of increased alcohol and other drug use (AOD) as a means of coping with stressful events. Black JIY report engaging in comorbid alcohol and cannabis use to achieve temporary respite from discrimination-induced stress. While JIY engage in higher rates of comorbid alcohol and cannabis use compared to non-justice-involved youth, overall, Black JIY are less likely to be diverted to substance use treatment programs, less likely to engage in care after being released on probation, less likely to benefit from substance use treatment in terms of reduced risk of recidivism, and are more adversely affected by early onset of AOD activity than White JIY. To date, no known adolescent substance use treatment directly addresses ERD, the increased risk of AOD due to ERD, or explicitly presents tools on how to appropriately respond to AOD and discrimination distress among Black JIY. To address this problem, the investigator's research program aspires to improve the understanding of the impact of ERD on adolescent AOD within the Black JIY population. Individual interviews with Black JIY and focus groups with guardians of Black JIY and community members will be conducted. Data will be used to culturally adapt an adolescent substance use intervention. The culturally adapted intervention will then be piloted with 30 Black JIY.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
For Focus Groups and Interviews:
Black JIY Participants:
Inclusion criteria
Exclusion criteria
For Focus Groups and Interviews:
Adult Participants
Inclusion criteria
Exclusion criteria
For pilot feasibility study:
Black JIY Participants:
Inclusion criteria
Exclusion criteria
The Cannabis Youth Treatment Series (CYT) (MET/CBT12 model) aims to reduce alcohol and cannabis use.
Other names: Cannabis Youth Treatment Series
Time frame: After study completion, an average of 3 months
Participants will complete feasibility and acceptability questionnaires and provide qualitative data on likes and dislikes about the intervention, delivery, session structure, and content.
Time frame: Baseline, after each study visit, at study completion, up to 3 months post-intervention, an average of 6 months.
Participants will complete urinalysis
Time frame: Baseline, after each study visit, at study completion, up to 3 months post-intervention, an average of 6 months.
Participants will complete measures and questionnaires to monitor anxiety, depression, and trauma symptoms
Time frame: baseline, after study completion, and up to 3 months post-intervention, an average of 6 months.
Participants will complete a discrimination distress assessment measure
Contact information is provided by the study sponsor or research team.
University of California, San Francisco
Other
The Cultural Adaptation of an Alcohol and Other Drug Use Treatment for Black Justice Involved Youth
Acronym: CAST
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07731295
Chemically-Induced Disorders, Mental Disorders
Providence, Rhode Island, United States
View Trial DetailsNCT07516301
Chemically-Induced Disorders, Mental Disorders
Memphis, Tennessee, United States
View Trial DetailsNCT07340554
Addiction, Addiction, Substance
Indianapolis, Indiana, United States
View Trial DetailsNCT07378254
Chemically-Induced Disorders, Mental Disorders
Piscataway, New Jersey, United States
View Trial Details